EntryPoint Capital’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-28,502
Closed -$206K 934
2024
Q3
$206K Buy
+28,502
New +$206K 0.12% 461
2024
Q1
Sell
-7,066
Closed -$153K 1712
2023
Q4
$153K Buy
+7,066
New +$153K 0.15% 181